Given that ischemic brain stroke induces tau hyperphosphorylation due to the activation of a variety of tau kinases [19], inhibition of tau pathology and subsequent neurotoxicity may be a target for mitigating the course of post-stroke dementia. The gene discussed is MAPT; the disease is Stroke.